Similarly, eckol suppressed stemness and malignancies in glioma stem-like cells by inhibiting both the PI3k-Akt and MAPK signaling [32], and these pathways were previously found to be activated in cancer stem-like cells [33,34]. The gene discussed is AKT1; the disease is glioma.